XML 31 R20.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Revenue
 3 Months Ended
Mar. 31, 2024
Revenue [Abstract]  
REVENUE

14. REVENUE

 

We primarily offer the First Defense® product line to dairy and beef producers to prevent scours in newborn calves. Generally, our products are promoted to veterinarians as well as dairy and beef producers by our sales team and then sold through distributors. Our primary market is North America. We do sell into select international regions and may expand this international reach in the future. There were no material changes between the allocation and timing of revenue recognition during the three-month periods ended March 31, 2024 or 2023. We do not have any contract assets for which we have satisfied the performance obligations, but do not yet have the right to bill for, or contract liabilities such as customer advances. All trade receivables on our balance sheet are from contracts with customers. We incur no material costs to obtain contracts.

 

The following table presents our product sales disaggregated by geographic area:

 

  

During the Three-Month Periods Ended March 31,

 
   2024   %   2023   % 
United States  $6,340,641    87%  $2,996,154    87%
Other   916,936    13%   450,373    13%
Total Product Sales  $7,257,577    100%  $3,446,527    100%

 

The following table presents our product sales disaggregated by major product category:

 

   During the Three-Month Periods Ended March 31, 
   2024   %   2023   % 
First Defense® product line  $7,220,641    99%  $3,411,232    99%
Other animal health   36,936    1%   35,295    1%
Total Product Sales  $7,257,577    100%  $3,446,527    100%